Literature DB >> 22901541

Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex.

S Mehdi Belgnaoui1, Suzanne Paz, Sara Samuel, Marie-Line Goulet, Qiang Sun, Marjolein Kikkert, Kazuhiro Iwai, Ivan Dikic, John Hiscott, Rongtuan Lin.   

Abstract

The RIG-I/Mda5 sensors recognize viral intracellular RNA and trigger host antiviral responses. RIG-I signals through the adaptor protein MAVS, which engages various TRAF family members and results in type I interferon (IFNs) and proinflammatory cytokine production via activation of IRFs and NF-κB, respectively. Both the IRF and NF-κB pathways also require the adaptor protein NEMO. We determined that the RIG-I pathway is differentially regulated by the linear ubiquitin assembly complex (LUBAC), which consists of the E3 ligases HOIL-1L, HOIP, and the accessory protein SHARPIN. LUBAC downregulated virus-mediated IFN induction by targeting NEMO for linear ubiquitination. Linear ubiquitinated NEMO associated with TRAF3 and disrupted the MAVS-TRAF3 complex, which inhibited IFN activation while stimulating NF-κB-dependent signaling. In SHARPIN-deficient MEFs, vesicular stomatitis virus replication was decreased due to increased IFN production. Linear ubiquitination thus switches NEMO from a positive to a negative regulator of RIG-I signaling, resulting in an attenuated IFN response.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901541     DOI: 10.1016/j.chom.2012.06.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  63 in total

1.  Regulation of mitochondrial antiviral signaling (MAVS) expression and signaling by the mitochondria-associated endoplasmic reticulum membrane (MAM) protein Gp78.

Authors:  Jana L Jacobs; Jianzhong Zhu; Saumendra N Sarkar; Carolyn B Coyne
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

Review 2.  Mechanisms and pathways of innate immune activation and regulation in health and cancer.

Authors:  Jun Cui; Yongjun Chen; Helen Y Wang; Rong-Fu Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

Review 4.  Linear ubiquitin chains: NF-κB signalling, cell death and beyond.

Authors:  Kazuhiro Iwai; Hiroaki Fujita; Yoshiteru Sasaki
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07-09       Impact factor: 94.444

Review 5.  RBR E3-ligases at work.

Authors:  Judith J Smit; Titia K Sixma
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

Review 6.  Ubiquitination in the antiviral immune response.

Authors:  Meredith E Davis; Michaela U Gack
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

7.  Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract.

Authors:  Junji Xing; Leiyun Weng; Bin Yuan; Zhuo Wang; Li Jia; Rui Jin; Hongbo Lu; Xian Chang Li; Yong-Jun Liu; Zhiqiang Zhang
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

8.  Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production.

Authors:  Shanping He; Jun Zhao; Shanshan Song; Xiaojing He; Arlet Minassian; Yu Zhou; Junjie Zhang; Kevin Brulois; Yuqi Wang; Jackson Cabo; Ebrahim Zandi; Chengyu Liang; Jae U Jung; Xuewu Zhang; Pinghui Feng
Journal:  Mol Cell       Date:  2015-03-05       Impact factor: 17.970

9.  Regulation of RNF144A E3 Ubiquitin Ligase Activity by Self-association through Its Transmembrane Domain.

Authors:  Shiuh-Rong Ho; Yu-Ju Lee; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

10.  Innate immune-directed NF-κB signaling requires site-specific NEMO ubiquitination.

Authors:  Janice C Jun; Sylvia Kertesy; Mark B Jones; Jill M Marinis; Brian A Cobb; Justine T Tigno-Aranjuez; Derek W Abbott
Journal:  Cell Rep       Date:  2013-07-18       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.